Clinical Trials Directory

Trials / Terminated

TerminatedNCT01834339

EVPOME Versus AlloDerm in Subjects Reconstructed With Large Defect Mandibular Resection

A Randomized, Parallel-Group (Autogenous EVPOME Versus AlloDerm Without Incorporation of Keratinocytes) Study in Subjects Reconstructed With Large Defect Mandibular Resection in Need of Vestibuloplasty for Dental Rehabilitation

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
1 (actual)
Sponsor
Stephen E. Feinberg · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the safety and effectiveness of performing oral reconstructive surgeries using either AlloDerm, a product commonly used for this purpose, or AlloDerm that has been overlaid with the subject's oral mucosal cells and developed into a type of graft that is called an ex vivo produced oral mucosal equivalent, EVPOME.

Conditions

Interventions

TypeNameDescription
BIOLOGICALAlloDerm
BIOLOGICALEVPOME

Timeline

Start date
2013-09-01
Primary completion
2014-11-01
Completion
2015-12-01
First posted
2013-04-17
Last updated
2017-11-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01834339. Inclusion in this directory is not an endorsement.

EVPOME Versus AlloDerm in Subjects Reconstructed With Large Defect Mandibular Resection (NCT01834339) · Clinical Trials Directory